Engraftment of CD34+ Cells in Animals Preinjected With Irradiated CD34− Cells and in Splenectomized Animals as Compared to Controls
Experiment-150 . | Input . | % CD45-151 BM . | % CD45-151 Spleen . | % CD45-151 PB . |
---|---|---|---|---|
I | CD34− | <1.0 | <1.0 | <1.0 |
CD34+ | 18.2 ± 11.2 | 8.5 ± 4.7 | 3.7 ± 2.0 | |
CD34− and CD34+ | 14.8 ± 4.1 | 13.5 ± 1.9 | 2.6 ± 0.2 | |
II | CD34+ | 26.3 ± 1.2 | nd | nd |
CD34+ Spl-X | 19.4 ± 15.4 | — | nd |
Experiment-150 . | Input . | % CD45-151 BM . | % CD45-151 Spleen . | % CD45-151 PB . |
---|---|---|---|---|
I | CD34− | <1.0 | <1.0 | <1.0 |
CD34+ | 18.2 ± 11.2 | 8.5 ± 4.7 | 3.7 ± 2.0 | |
CD34− and CD34+ | 14.8 ± 4.1 | 13.5 ± 1.9 | 2.6 ± 0.2 | |
II | CD34+ | 26.3 ± 1.2 | nd | nd |
CD34+ Spl-X | 19.4 ± 15.4 | — | nd |
Abbreviations: BM, bone marrow; PB, peripheral blood; nd, not done.
Two independent experiments in which sublethally irradiated NOD/SCID mice were injected with CD34+ cells from a G-CSF–mobilized apheresis product. In experiment I, animals were either injected with 20 Gy irradiated monocyte-depleted (by plastic adherence for 30 minutes at 37°C) CD34− cells (25 × 106 per animal) alone, with CD34+ cells alone (9 × 106 per animal), or with CD34− cells followed by CD34+ cells four hours later (n = 2 per group). In experiment II, 12 × 106 CD34+cells were injected in splenectomized or nonsplenectomized animals (n = 2 per group).
Percentage human cells was determined by flow cytometry using an antibody specific for human CD45.